Related Experiment Video
Updated: Jul 18, 2026

Endoscopy Guided Photoablation of Endometrial Cysts using a 980 nm Laser with a Contact Fiber in Mares
Published on: July 16, 2020
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
L M Kettel1, A A Murphy, A J Morales
1University of California-San Diego, La Jolla, USA.
Objective:
To evaluate the safety and efficacy of an antiprogesterone (mifepristone, RU486; Roussel-Uclaf, Romaineville, France) on endometriosis.
Design:
An open, prospective clinical trial.
Setting:
The clinical practice of an academic faculty.
Patients:
Nine women with endometriosis were studied.
Interventions:
RU486 (50 mg/d) was administered for 6 months.
Main Outcome Measures:
Daily symptom inventories and urinary steroid metabolites were assessed before, during, and after treatment. Blood for hormone analysis was obtained weekly for 4 weeks and monthly thereafter. The extent of endometriosis, bone mineral density, circadian rhythm of cortisol, and LH pulsatility were determined before and after treatment. Safety laboratory measurements were made before and at 1, 2, and 6 months of treatment.
Results:
Pelvic pain and uterine cramping improved in all patients. Endometriosis regressed by 55%. All patients exhibited endocrine features of anovulatory amenorrhea without hypoestrogenism. A rise in serum LH and T levels was observed during the first month of treatment and one patient developed an elevation of liver transaminases during the last month of treatment. All other measurements were unchanged.
Conclusion:
RU486 appears to be effective in improving the symptoms and causing regression of endometriosis in the absence of significant side effects.
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle
Birth Control Methods
Intrauterine Drug Delivery Systems

